Acute Myeloid Leukemia, Adult Clinical Trials in Pierre-Bénite, France

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients